PAVmed director granted 13,930 restricted shares

White Debra reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/03/2026 - 04:48 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

White Debra reported acquisition or exercise transactions in this Form 4 filing.

PAVmed Inc. director Debra White received a grant of 13,930 shares of restricted common stock as compensation. The award was granted at $0.00 per share under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if the required service period is not completed. Following this grant, White directly holds 21,097 shares of PAVmed common stock.

Insider Trade Summary

Grant/Award: 13,930 shares

Grant/Award 1 txn

Insider White Debra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,930	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,097 shares (Direct)

Holdings Before and After: Common Stock, 7,167 to 21,097 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed,

Key Figures

Restricted stock grant: 13,930 shares Grant price: $0.00 per share Shares held after grant: 21,097 shares +1 more

4 metrics

Restricted stock grant 13,930 shares Awarded to director Debra White

Grant price $0.00 per share Equity compensation, not market purchase

Shares held after grant 21,097 shares Debra White direct ownership following transaction

Vesting date May 20, 2029 Single vesting date for restricted stock grant

Key Terms

restricted stock, vesting, forfeiture, Long-Term Incentive Equity Plan

4 terms

restricted stock financial

"Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vesting financial

"with a single vesting date of May 20, 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

forfeiture financial

"Such restricted stock is subject to forfeiture if the requisite service period is not completed"

Long-Term Incentive Equity Plan financial

"under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PAVmed (PAVM) director Debra White report?

Debra White reported receiving 13,930 shares of restricted PAVmed common stock as a grant. The award was made at $0.00 per share under the company’s long-term incentive equity plan and represents compensation rather than an open-market purchase or sale.

How many PAVmed (PAVM) shares does Debra White hold after this grant?

After the restricted stock grant, Debra White directly holds 21,097 shares of PAVmed common stock. This reflects the addition of 13,930 restricted shares awarded in the reported transaction, all held in a direct ownership capacity according to the filing.

When do Debra White’s newly granted PAVmed restricted shares vest?

The 13,930 restricted PAVmed shares granted to Debra White have a single vesting date of May 20, 2029. Vesting requires completion of a specified service period, and the shares are subject to forfeiture if that service condition is not satisfied.

Was Debra White’s PAVmed stock transaction a market purchase or sale?

The reported transaction was not a market purchase or sale. It was a grant or award acquisition of 13,930 restricted shares at $0.00 per share, provided as equity compensation under PAVmed’s long-term incentive equity plan rather than through open-market trading.

What plan governs Debra White’s restricted stock grant at PAVmed (PAVM)?

The restricted stock grant was made under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. This plan provides equity-based compensation, including restricted stock awards, with vesting and forfeiture conditions tied to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

White Debra

(Last) (First) (Middle)

360 MADISON AVENUE

25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		13,930(1)	A	$0	21,097	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed,

	/s/ Michael A. Gordon, by power of attorney	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)